Neola Medical AB (publ) (STO:NEOLA)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.5000
-0.0200 (-3.85%)
Nov 4, 2026, 5:25 PM CET

Neola Medical AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
55831421092855
Market Cap Growth
-60.96%-41.69%30.50%282.12%-48.28%-3.33%
Enterprise Value
5161118822050
Last Close Price
0.501.021.951.881.302.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1453.642174.402725.072648.5093.4840.13
PB Ratio
0.571.092.061.370.421.35
P/TBV Ratio
0.571.092.061.370.421.35

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-1592.222260.431999.4066.3136.81

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-0.04-0.21-0.28-0.27-0.59-0.56
Net Debt / EBITDA Ratio
0.361.662.082.634.203.46
Net Debt / FCF Ratio
0.361.461.793.304.663.23
Asset Turnover
000.000.000.010.04
Quick Ratio
5.425.604.436.907.697.64
Current Ratio
5.425.754.537.007.787.76
Return on Equity (ROE)
-14.20%-15.23%-13.60%-12.30%-19.15%-20.73%
Return on Assets (ROA)
-8.36%-9.10%-8.46%-7.46%-10.62%-11.92%
Return on Capital Employed (ROCE)
-13.00%-14.60%-15.70%-12.10%-14.50%-16.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-32.68%-13.34%-7.10%-8.30%-36.43%-12.11%
FCF Yield
-20.13%-13.40%-7.70%-6.02%-30.26%-12.93%
Buyback Yield / Dilution
-6.82%-8.93%-25.80%-113.90%-86.03%-48.67%